Dx Revision Watch
Suzy Chapman Owner of Dx Revision Watch
- Messages
- 3,061
- Location
- UK
In March, this year, Dr Esther Crawley* gave a presentation to a Dorset patient support group entitled “The Future of Research in CFS/ME” [/B during which she also spoke on XMRV research and delivered some very controversial comment on the operation and findings of the Whittemore Peterson Institute (WPI).
It is understood that the presentation was attended by Annette Brooke (MP for Mid Dorset and North Poole) and Vice-Chair of the re-formed APPG on ME and also by Bournemouth based Lightning Process practitioner, Alastair Gibson (Withinspiration), who is a collaborator in the research team for the Bath/Bristol LP pilot study in children, for which Dr Crawley is lead researcher.
Published today, on ME agenda, is an unofficial transcript that has been provided to me to supplement the partial transcript that was first published on ME agenda, in August. The transcript includes the text of most of the PowerPoint slides that were used during Dr Crawley's presentation.
The Tiny URL link for this post is: http://tinyurl.com/Crawley-Presentation-March-10
The WordPress Shortlink is: http://wp.me/p5foE-3ay
Dorset CFS/ME Society
Annual Medical Lecture
27th March 2010
The Future of Research in CFS/ME
Esther Crawley
It’s a great pleasure to be here, everybody, and I’m really glad actually that my talk actually fits in very nicely with what William’s just said. Phew!
I’m going to be talking a lot about the collaborative research and the first half of my talk actually was given to the MRC Working Group at the end of last year. So you’ll actually see what we were talking about where the MRC gathered lots and lots of researchers together to discuss a way forward with chronic fatigue [sic] and I did the talk on epidemiology.
And, actually, on a sort of personal level, [I am] particularly proud because my gorgeous son is sitting in the front row, grinning from ear to ear about his Mummy, so that’s a great joy and it’s lovely to see so many of you again.
Slide 1: The future of research
So in the talk today, I’m going to talk about the future of research and I believe there is strongly… that there are two really important arms for research in chronic fatigue syndrome. The first is about how we [are] actually, really quickly, going to change what happens to patients and carers and, to do that, we need to understand much more about the epidemiology, and my children asked me what that meant this morning, and that’s the study of populations. We need to understand more about who it affects, how to treat it and about the different disease groups, because you all know that there are different types of chronic fatigue syndrome.
And the second arm of research is the arm into aetiology: what causes chronic fatigue syndrome. And, of course, that’s the bit that we researchers really enjoy doing. That’s the bit that makes us excited. I don’t actually agree that research is demeaning. I think that I’ve got the best job in the world, actually.
And the aetiology and the pathogenesis and my PhD was genetics. That’s what really excites us. But, realistically, it’s not going to have the same gains at a patient level or a population level as understanding more about the illness.
And, realistically, the aetiology research has to be done on a background of understanding much more about what this illness is, otherwise we’ll get the wrong answers.
So I’m going to talk about both.
And I couldn’t resist talking about XMRV. I think we have to know about what’s actually happened and I will discuss that as well and what the implications are.
So, the epidemiology. What is this illness? Who does it affect...
Read the rest of this transcript >>
*Dr Esther Crawley
Dr Crawley, FRCPCH, PhD, is a Senior Lecturer at the University of Bristol, a Consultant Paediatrician and clinical lead for the Bath CFS service. Dr Crawley’s specialist CFS service for children and adolescents is reported to be the largest regional paediatric service in the UK and also provides services nationally.
Dr Crawley had been a member of the NICE CFS/ME Guideline Development Group and gives presentations around the NICE guideline CG53 and the CFS/ME Clinical and Research Network.
Dr Crawley had chaired the CFS/ME Clinical Research Network Collaborative (CCRNC), now reformed under the new name “BACME”, for which Dr Crawley continues as chair.
Dr Crawley is a member of the MRC’s “CFS/ME Expert Panel”.
In the last couple of years, Dr Crawley’s research team has been awarded considerable sums of funding for CFS studies and Chronic Fatigue studies in children – including a 873,579 NIHR Clinician Scientist Fellowship award, last year. She has also received funding from patient organisation, Action for M.E. (49,650).
Grants awarded to Dr Crawley during 2007-09 here: http://www.bristol.ac.uk/ccah/grants/
[1] Radio 4 Case Notes: Dr Crawley on CFS clinic approach, November 2007:
http://www.bbc.co.uk/radio4/science/casenotes_tr_20071106.shtml
[2] RNHRD Bath Chronic Fatigue Syndrome/ME Service for Children & Young People:
http://www.rnhrd.nhs.uk/departments/chronic_fatigue_syndrome_children.htm
It is understood that the presentation was attended by Annette Brooke (MP for Mid Dorset and North Poole) and Vice-Chair of the re-formed APPG on ME and also by Bournemouth based Lightning Process practitioner, Alastair Gibson (Withinspiration), who is a collaborator in the research team for the Bath/Bristol LP pilot study in children, for which Dr Crawley is lead researcher.
Published today, on ME agenda, is an unofficial transcript that has been provided to me to supplement the partial transcript that was first published on ME agenda, in August. The transcript includes the text of most of the PowerPoint slides that were used during Dr Crawley's presentation.
The Tiny URL link for this post is: http://tinyurl.com/Crawley-Presentation-March-10
The WordPress Shortlink is: http://wp.me/p5foE-3ay
Dorset CFS/ME Society
Annual Medical Lecture
27th March 2010
The Future of Research in CFS/ME
Esther Crawley
It’s a great pleasure to be here, everybody, and I’m really glad actually that my talk actually fits in very nicely with what William’s just said. Phew!
I’m going to be talking a lot about the collaborative research and the first half of my talk actually was given to the MRC Working Group at the end of last year. So you’ll actually see what we were talking about where the MRC gathered lots and lots of researchers together to discuss a way forward with chronic fatigue [sic] and I did the talk on epidemiology.
And, actually, on a sort of personal level, [I am] particularly proud because my gorgeous son is sitting in the front row, grinning from ear to ear about his Mummy, so that’s a great joy and it’s lovely to see so many of you again.
Slide 1: The future of research
• Providing services and treatment
• Epidemiology
• Different disease types
• Evaluation of treatment
• Impact
• Understanding the cause
• Genetics and GWAS
• Infection and XMRV?
• Epidemiology
• Different disease types
• Evaluation of treatment
• Impact
• Understanding the cause
• Genetics and GWAS
• Infection and XMRV?
So in the talk today, I’m going to talk about the future of research and I believe there is strongly… that there are two really important arms for research in chronic fatigue syndrome. The first is about how we [are] actually, really quickly, going to change what happens to patients and carers and, to do that, we need to understand much more about the epidemiology, and my children asked me what that meant this morning, and that’s the study of populations. We need to understand more about who it affects, how to treat it and about the different disease groups, because you all know that there are different types of chronic fatigue syndrome.
And the second arm of research is the arm into aetiology: what causes chronic fatigue syndrome. And, of course, that’s the bit that we researchers really enjoy doing. That’s the bit that makes us excited. I don’t actually agree that research is demeaning. I think that I’ve got the best job in the world, actually.
And the aetiology and the pathogenesis and my PhD was genetics. That’s what really excites us. But, realistically, it’s not going to have the same gains at a patient level or a population level as understanding more about the illness.
And, realistically, the aetiology research has to be done on a background of understanding much more about what this illness is, otherwise we’ll get the wrong answers.
So I’m going to talk about both.
And I couldn’t resist talking about XMRV. I think we have to know about what’s actually happened and I will discuss that as well and what the implications are.
So, the epidemiology. What is this illness? Who does it affect...
Read the rest of this transcript >>
*Dr Esther Crawley
Dr Crawley, FRCPCH, PhD, is a Senior Lecturer at the University of Bristol, a Consultant Paediatrician and clinical lead for the Bath CFS service. Dr Crawley’s specialist CFS service for children and adolescents is reported to be the largest regional paediatric service in the UK and also provides services nationally.
Dr Crawley had been a member of the NICE CFS/ME Guideline Development Group and gives presentations around the NICE guideline CG53 and the CFS/ME Clinical and Research Network.
Dr Crawley had chaired the CFS/ME Clinical Research Network Collaborative (CCRNC), now reformed under the new name “BACME”, for which Dr Crawley continues as chair.
Dr Crawley is a member of the MRC’s “CFS/ME Expert Panel”.
In the last couple of years, Dr Crawley’s research team has been awarded considerable sums of funding for CFS studies and Chronic Fatigue studies in children – including a 873,579 NIHR Clinician Scientist Fellowship award, last year. She has also received funding from patient organisation, Action for M.E. (49,650).
Grants awarded to Dr Crawley during 2007-09 here: http://www.bristol.ac.uk/ccah/grants/
[1] Radio 4 Case Notes: Dr Crawley on CFS clinic approach, November 2007:
http://www.bbc.co.uk/radio4/science/casenotes_tr_20071106.shtml
[2] RNHRD Bath Chronic Fatigue Syndrome/ME Service for Children & Young People:
http://www.rnhrd.nhs.uk/departments/chronic_fatigue_syndrome_children.htm